|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
T2 Biosystems, Inc. (TTOO) |
|
|
$0.17 0.00 (0.00%) as of 4:30 Thu 10/12
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
16,340,000 |
| Market
Cap: |
2.84(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.0623 - $0.5911 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile T2 Biosystems is an in vitro diagnostics company and engaged in the detection of sepsis-causing pathogens and antibiotic resistance genes. Co.'s products include: T2Dx® Instrument, which runs diagnostic tests from patient samples; T2Candida® Panel, which is a direct-from-blood test that identifies the lethal form of blood stream infections that cause sepsis candidemia; T2Bacteria® Panel, which is a direct-from-blood test that detects bacterial pathogens associated with sepsis; T2Resistance® Panel, which is a direct-from-blood test that detects resistance genes from both gram-positive and gram-negative pathogens; and T2SARS-CoV-2™ Panel, which detect SARS-CoV-2, the coronavirus in patients.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
48,345,798 |
48,364,599 |
| Total Sell Value |
$0 |
$0 |
$12,851,221 |
$12,864,540 |
| Total People Sold |
0 |
0 |
1 |
5 |
| Total Sell Transactions |
0 |
0 |
8 |
18 |
| End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Lowery Thomas J. |
Chief Scientific Officer |
• – – |
2015-04-20 |
4 |
OE |
$1.16 |
$1,160 |
D/D |
1,000 |
6,882 |
|
- |
|
| Mcdonough John |
President and CEO |
• • – |
2015-03-27 |
4 |
OE |
$1.16 |
$34,800 |
D/D |
30,000 |
184,763 |
|
- |
|
| Kalil Sarah O. |
Chief Operating Officer |
• – – |
2015-03-27 |
4 |
OE |
$3.22 |
$133,630 |
D/D |
41,500 |
56,500 |
|
- |
|
| Elsbree David B |
Director |
– • – |
2015-03-04 |
4 |
B |
$15.05 |
$21,823 |
I/I |
1,450 |
3,950 |
2.1 |
- |
|
| Elsbree David B |
Director |
– • – |
2014-11-13 |
4 |
B |
$14.75 |
$22,125 |
I/I |
1,500 |
2,500 |
2.1 |
- |
|
| Elsbree David B |
Director |
– • – |
2014-10-07 |
4 |
GA |
$0.00 |
$0 |
I/I |
1,000 |
1,000 |
|
- |
|
| Elsbree David B |
Director |
– • – |
2014-10-07 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,000 |
14,000 |
|
- |
|
| Kalil Sarah O. |
Chief Operating Officer |
• – – |
2014-08-12 |
4 |
B |
$11.00 |
$55,000 |
I/I |
5,000 |
5,000 |
1.99 |
- |
|
| Elsbree David B |
Director |
– • – |
2014-08-12 |
4 |
B |
$11.00 |
$165,000 |
D/D |
15,000 |
15,000 |
2.39 |
- |
|
| Crane Alan L |
Director |
– • – |
2014-08-12 |
4 |
B |
$11.00 |
$330,000 |
D/D |
30,000 |
30,000 |
2.39 |
- |
|
| Elms Steve |
10% Owner |
– – • |
2014-08-12 |
4 |
B |
$11.00 |
$4,999,995 |
I/I |
454,545 |
2,523,300 |
1.5 |
- |
|
| Elms Steve |
10% Owner |
– – • |
2014-08-12 |
4 |
A |
$0.00 |
$0 |
I/I |
2,068,755 |
2,068,755 |
|
- |
|
| Kania Edwin M Jr |
10% Owner |
– – • |
2014-08-12 |
4 |
A |
$0.00 |
$0 |
I/I |
2,374,571 |
2,374,571 |
|
- |
|
| Cima Michael J. |
Director |
– • – |
2014-08-12 |
4 |
B |
$11.00 |
$22,000 |
D/D |
2,000 |
181,018 |
2.39 |
- |
|
| Cima Michael J. |
Director |
– • – |
2014-08-12 |
4 |
A |
$0.00 |
$0 |
D/D |
2,548 |
179,018 |
|
- |
|
| Kalil Sarah O. |
Chief Operating Officer |
• – – |
2014-08-12 |
4 |
B |
$11.00 |
$165,000 |
D/D |
15,000 |
15,000 |
2.74 |
- |
|
| Mbd 2013 Offshore, L.p. |
|
– – • |
2014-08-12 |
4 |
B |
$11.00 |
$9,999,990 |
I/I |
909,090 |
3,457,240 |
0.01 |
- |
|
| Mbd 2013 Offshore, L.p. |
|
– – • |
2014-08-12 |
4 |
A |
$0.00 |
$0 |
I/I |
2,548,150 |
2,548,150 |
|
- |
|
| Mbd Advisors, L.l.c. |
|
– – • |
2014-08-12 |
4 |
B |
$11.00 |
$9,999,990 |
I/I |
909,090 |
3,457,240 |
0.01 |
- |
|
| Mbd Advisors, L.l.c. |
|
– – • |
2014-08-12 |
4 |
A |
$0.00 |
$0 |
I/I |
2,548,150 |
2,548,150 |
|
- |
|
| Carella Thomas J. |
|
– • – |
2014-08-12 |
4 |
B |
$11.00 |
$9,999,990 |
I/I |
909,090 |
3,457,240 |
0.01 |
- |
|
| Carella Thomas J. |
|
– • – |
2014-08-12 |
4 |
A |
$0.00 |
$0 |
I/I |
2,548,150 |
2,548,150 |
|
- |
|
| Polaris Venture Management Co. V, L.l.c. |
10% Owner |
– – • |
2014-08-12 |
4 |
A |
$0.00 |
$0 |
I/I |
2,374,571 |
2,374,571 |
|
- |
|
| Mcdonough John |
President & CEOOfficer |
• • – |
2014-08-06 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
154,763 |
|
- |
|
| Cima Michael J. |
Director |
– • – |
2014-08-06 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
176,470 |
|
- |
|
351 Records found
|
|
Page 14 of 15 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
